Review of the use of Topiramate for treatment of psychiatric disorders - Wikidata - awgldk - TriplyDB

Review of the use of Topiramate for treatment of psychiatric disorders

Review of the use of Topiramate for treatment of psychiatric disorders

http://www.wikidata.org/entity/Q24523918

about

sameAs

The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm Effectiveness of topiramate for tobacco dependence in patients with depression; a randomised, controlled trial A meta-analysis of topiramate's effects for individuals with alcohol use disorders.Efficacy of zonisamide in migraineurs with nonresponse to topiramate.Topiramate as a therapy for chronic posttraumatic stress disorder.Pharmacotherapy for treatment-resistant schizophrenia.Bilateral acute angle-closure glaucoma following treatment with topiramate for headache.Proteomic and metabolomic profiling of a trait anxiety mouse model implicate affected pathways Prescription of topiramate to treat alcohol use disorders in the Veterans Health Administration Efficacy of add-on topiramate therapy in psychiatric patients with weight gain.Adjunctive lithium and anticonvulsants for the treatment of schizophrenia: what is the evidence?Pharmacoprophylaxis of alcohol dependence: Review and update Part I: Pharmacology.Clinical psychopharmacology of eating disorders: a research update.Topiramate induced pruritus in a patient with alcohol dependence.Safety assessment of combination therapies in the treatment of obesity: focus on naltrexone/bupropion extended release and phentermine-topiramate extended release.Investigational drugs in Phase I and Phase II for Levodopa-induced dyskinesias.Topiramate-induced psychosis in two members of the one family: a case report Topiramate Combined with Cognitive Restructuring for the Treatment of Gambling Disorder: A Two-Center, Randomized, Double-Blind Clinical Trial.New-onset Panic Attacks Associated with Topiramate.Topiramate add-on treatment associated with normalization of prolactin levels in a patient with schizophrenia.Glaucoma: Adverse event on use of topiramate in alcohol de-addiction.The antidepressant-like effects of topiramate alone or combined with 17β-estradiol in ovariectomized Wistar rats submitted to the forced swimming test.Topiramate augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study.Compulsive buying treatment with topiramate, a case report.Advances in Pharmacotherapy Development: Human Clinical Studies.The investigation of the effects of topiramate on the hypothalamic levels of fat mass/obesity-associated protein and neuropeptide Y in obese female rats.Topiramate via NMDA, AMPA/kainate, GABAA and Alpha2 receptors and by modulation of CREB/BDNF and Akt/GSK3 signaling pathway exerts neuroprotective effects against methylphenidate-induced neurotoxicity in rats.Neuroprotective effects of various doses of topiramate against methylphenidate-induced oxidative stress and inflammation in isolated rat amygdala: the possible role of CREB/BDNF signaling pathway.Topiramate does not affect the acquisition or expression of ethanol conditioned place preference in DBA/2J or C57BL/6J mice.Neuroprotective effects of various doses of topiramate against methylphenidate induced oxidative stress and inflammation in rat isolated hippocampus.Predictors of Topiramate Tolerability in Heavy Cannabis-Using Adolescents and Young Adults: A Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial.

P2860

Q28066714-7E460098-FEEE-4ADD-A40B-8E5A057546C2 Q33332371-73CC6E25-682C-4BE8-970C-971A66B79258 Q33717597-6DBD3F3D-6D77-4692-9DC8-ABB0B8FEC890 Q33914523-F706D68A-1E13-42FE-91BF-72C65E7069FF Q34343911-A440763B-3CEF-47A9-8F39-E27F06021A61 Q34879109-889344AA-F44B-43B9-8B7D-34DD96425A06 Q35309277-342703B7-9FCD-4362-9BAA-06FD3952225A Q35610645-539480B3-DC36-4993-9243-4DCBF3CEF0E7 Q37028407-5661C3CD-C9D2-45A2-B74D-813EBC798633 Q37118263-3B05C135-FAA9-4FD2-9FD5-A7513FB9F25D Q37356492-DB398B62-F12E-441F-B4FD-DEA701C69ED9 Q37773792-A2760AF5-437D-49EE-BA13-90AEF122C511 Q37857919-5C9A2D0F-1125-4406-B39E-4827A327C372 Q38549718-2B84D86C-A1B8-4AAB-9324-7AC9D3E2EFF4 Q38812405-28D69124-17FD-4E6B-A234-9403E2FD4D8C Q39324877-68B72E8C-E78E-476B-B3FF-9CFE9128F1C7 Q39423522-A1183AFF-CC5B-45DE-9AD0-1C0961A302D1 Q39713624-B516404F-2485-4B4D-95D8-F156D3943C7F Q41574600-40C4AF29-FD3B-4AA3-9EDD-C2AA2F934D1F Q42058133-CD805534-6DC2-41AE-A017-49D9F80B7DAF Q42805389-97A287ED-9A69-4988-997A-BBBEF0257310 Q43951261-E716D7B1-6341-4A6E-8C18-F97BC863BB2B Q45810988-A8520641-5EBE-44FC-9411-C1C32F857E2B Q46804620-5C6232B4-61A3-4B1D-9922-6509EE35CC28 Q47182010-FE56FF6C-B774-47CE-A6EB-8C1EAB3A3860 Q47252184-257546CF-E713-452D-92A0-CF0705707013 Q47970322-FE6B00AE-18E3-45E4-81F7-A2727101738E Q48496511-E227C010-901F-4584-9CBC-1CCB08F03FB3 Q48570315-AB9BD435-3454-4FDA-A4B6-496463B7EF7A Q49070636-218E9A98-C568-4569-A6D2-904AE11ACEA1 Q50101197-72B6828E-FA4B-433C-B05B-3591DA43C34F

P2860

Review of the use of Topiramate for treatment of psychiatric disorders

http://www.wikidata.org/entity/Q24523918

description

2005 nî lūn-bûn

@nan

2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Review of the use of Topiramate for treatment of psychiatric disorders

@ast

Review of the use of Topiramate for treatment of psychiatric disorders

@en

Review of the use of Topiramate for treatment of psychiatric disorders

@en-gb

Review of the use of Topiramate for treatment of psychiatric disorders

@nl

type

label

Review of the use of Topiramate for treatment of psychiatric disorders

@ast

Review of the use of Topiramate for treatment of psychiatric disorders

@en

Review of the use of Topiramate for treatment of psychiatric disorders

@en-gb

Review of the use of Topiramate for treatment of psychiatric disorders

@nl

prefLabel

Review of the use of Topiramate for treatment of psychiatric disorders

@ast

Review of the use of Topiramate for treatment of psychiatric disorders

@en

Review of the use of Topiramate for treatment of psychiatric disorders

@en-gb

Review of the use of Topiramate for treatment of psychiatric disorders

@nl

P1433

Q24523918-D6EEC3F7-2D18-44E1-9A3C-83B86A397602

P1476

Q24523918-4C55C0D2-4084-4224-AD30-4336B51133F0

P2860

Q24523918-05824478-4042-43F3-99C2-E9A8350BEDE0

Q24523918-0B3F7789-55E4-4362-A1D1-1C2851E95279

Q24523918-0CA9CB2E-3F89-4A5B-B752-A933773B986A

Q24523918-0E83D49B-1EAB-450C-9291-2625967D162F

Q24523918-0F93DB20-75C3-45EF-8FC8-AEF555B545E2

Q24523918-11305A1F-ED0C-4964-B17D-5CE6684B0C44

Q24523918-128537CF-1E65-43E2-B63A-5070AEC2CD58

Q24523918-13A9C874-089D-409D-93B2-240544230A90

Q24523918-152B2E39-8E36-4317-BA5F-667D35A96BBB

Q24523918-15477DF5-F052-4A34-919D-32DBAF8477D2

P2888

Q24523918-D763C1C7-1E12-4172-AD6F-B12C45F3CA7D

P304

Q24523918-718A6994-1896-480C-AD2B-35D283F47CA1

P31

Q24523918-840ED109-9DEA-4587-828A-5FB6DFB3EAFC

P356

Q24523918-00E4A91F-F9B7-4B00-8875-4E699BFC0FB1

P433

Q24523918-40A0D180-FC7B-4294-8815-ADA343453A03

P478

Q24523918-CEE55A2A-7B24-4E55-A5C9-69E7E0C1AE0E

P50

Q24523918-95E85656-F7F9-4E20-8719-D163A6C3B4D0

P577

Q24523918-10B3E358-6CA0-41B0-920E-848BC5B3E4B1

Q24523918-F477EB77-F950-46AC-9BCD-0080B625D581

P6179

Q24523918-20D6A076-CB12-4ACD-B598-34198C0B3FCF

P698

Q24523918-BEC2D687-24D4-4775-ADE1-22E546970F2E

P932

Q24523918-DBACECF2-6645-4A71-B73C-CAE36AB6311A

P356

P1433

Annals of General Psychiatry

P1476

Review of the use of Topiramate for treatment of psychiatric disorders

@en

P2860

A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group

Antipsychotic-induced weight gain: a comprehensive research synthesis

Topiramate: a review of preclinical, pharmacokinetic, and clinical data.

A glutamatergic deficiency model of schizophrenia.

Guidelines for healthy weight.

Use of atypical antipsychotic agents in bipolar and schizoaffective disorders: review of the empirical literature.

Weight gain associated with use of psychotropic medications.

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder.

Treatment of binge-eating disorder with topiramate: a clinical case series.

P2888

P304

5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1744-859X-4-5

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2005-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1004434139

http://www.w3.org/2001/XMLSchema#string

P698

15845141

http://www.w3.org/2001/XMLSchema#string

P932

1088011

http://www.w3.org/2001/XMLSchema#string